Home › Calculator › SHEZF Dividend Calculator 2026
SHEZF Dividend DRIP Calculator 2026
4.51% YieldHealthcareShenzhen Hepalink Pharmaceutical Group Co., Ltd. · OTC
Price: $0.47 · Annual div: $0.02/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SHEZF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your SHEZF snowball 📈
$10,000 in SHEZF → $992.85M in 10 years · $79,324,017.96/month
About Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) — Dividend Analysis 2026
Shenzhen Hepalink Pharmaceutical Group Co., Ltd., established in 1998 and headquartered in Shenzhen, People's Republic of China, operates as a global pharmaceutical enterprise. Having adopted its current name in February 2017 (formerly Shenzhen Hepalink Pharmaceutical Co.,Ltd.), the company specializes in the production and worldwide distribution of pharmaceutical products across diverse markets including Hong Kong, the United States, Europe, and mainland China. Its comprehensive business operations are structured into four key divisions: finished dose pharmaceutical products, active pharmaceutical ingredients (APIs), contract development and manufacturing organization (CDMO) services, and an 'other' category. Hepalink's product lineup prominently features finished dosage forms such as enoxaparin sodium injection, alongside essential APIs like heparin sodium and enoxaparin sodium, and other specialized APIs including pancreatin. Beyond manufacturing, the firm provides extensive services covering research and development, production, quality control, and program management. It also engages in the innovation and creation of sophisticated biopharmaceuticals, specifically recombinant products, crucial non-viral vectors, gene therapy intermediates, and pharmaceutical compounds originating from natural sources. Further diversifying its portfolio, Hepalink's broader interests span property management, investment and biopharmaceutical technology consulting, and equity and venture investments. The company also undertakes general biopharmaceutical research, development, and production, manages the sale of heparin sodium, offers various pharmaceutical-related services, and actively trades medical and biopharmaceutical goods.
Compare SHEZF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SHEZF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SHEZF position with:
🌍 SHEZF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SHEZF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 4.51% | 1.71% | $451 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3.83% | 1.03% | $383 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.61% | 0.81% | $361 / yr |
| 🇬🇧 UK ISA | 0% | 4.51% | 1.71% | $451 / yr |
| 🇬🇧 UK Taxable | 8.75% | 4.12% | 1.32% | $412 / yr |
| 🇨🇦 TFSA | 0% | 4.51% | 1.71% | $451 / yr |
| 🇨🇦 CA Taxable | 25% | 3.38% | 0.58% | $338 / yr |
| 🇦🇺 Super (pension) | 15% | 3.83% | 1.03% | $383 / yr |
| 🇦🇺 AU Taxable | 30% | 3.16% | 0.36% | $316 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.32% | 0.52% | $332 / yr |
| 🇫🇷 FR Taxable | 30% | 3.16% | 0.36% | $316 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SHEZF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.02/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SHEZF Dividend Payment Schedule
SHEZF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 SHEZF vs Healthcare Benchmarks
How SHEZF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SHEZF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SHEZF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SHEZF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) is currently trading at $0.47, trading near its 52-week low. The current dividend yield is 4.51% based on an annual payout of $0.02 per share.
SHEZF (Shenzhen Hepalink Pharmaceutical Group Co., Ltd.) — 4.51% Dividend Yield Analysis
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) is a healthcare stock currently trading at $0.47 with a dividend yield of 4.51%. The company pays an annual dividend of $0.02 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, SHEZF has grown its dividend at a compound annual rate of 77.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest SHEZF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.